The kit is designed for detection of the hepatitis C virus and its genotypes (1a,1b, 2, 3, 4, 5a, 6) in patients with the detected virus to choose an appropriate antiviral therapy, to predict and evaluate the course of the disease and possible complications.
The kit is designed for quantitative detection of the hepatitis C virus RNA in patients with suspected infection and patients with the detected hepatitis C virus in order to choose an appropriate therapy and evaluate its effectiveness.
The rapid test is designed for diagnostics and differentiation of the most dangerous respiratory viral infections: coronavirus and influenza A and B.
The rapid test is designed to diagnose a respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The rapid test is designed to diagnose a respiratory viral infection caused by the SARS- CoV-2 coronavirus.
TestGen develops test systems for molecular genetic testing monogenic and multifactorial hereditary diseases, oncology and prenatal diagnostics using real-time PCR and PCR followed by sequencing, which allow assessing the degree of genetic predisposition to the development of a particular genetic disease.
For research, human genomic DNA isolated from saliva, blood or other biological material is used.
Transportation and Storage conditions: -20°C 12 months / 4°C 6 months / to 30 °C 3 days